Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,079 public trials 2,046 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT02142049

Conditions
Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Hemic and Lymphatic Diseases, +7 more
Locations
  • SITE-1 Duarte, California, United States
  • SITE-2 Los Angeles, California, United States
  • SITE-10 Orange, California, United States
  • SITE-3 Chicago, Illinois, United States
View Trial Details
Completed

A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain

NCT03602755

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • H. Santiago (CHUS) Santiago de Compostela, A Coruña, Spain
  • H. Txagorritxu Vitoria-Gasteiz, Alava, Spain
  • H. Son Espases Palma, Balearic Islands, Spain
  • ICO Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
View all 20 locations
View Trial Details
Completed

Observational Study in CLL Patients Receiving BR

NCT02381899

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Department of Hematology - Oncology, University Hospital Brno, Czechia
  • 4th Department of Medicine - Hematology, University Hospital Hradec Králové, Czechia
  • Department of Hematology, University Hospital Pilsen, Czechia
  • Department of Medicine - Hematology, University Hospital Kralovske Vinohrady Prague, Czechia
View Trial Details
Completed

Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

NCT00928018

Conditions
Graft vs Host Disease, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations
  • Emory University Hospital Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions